亚洲精品自拍视频 I 精品人妻码一区二区三区 I 国产成人黄色在线观看 I 91视频国产一区 I 欧美高清freexxxx性 I 91久久天天躁狠狠躁夜夜 I 精品国偷自产在线视频九色 I 久久免费视频6 I 亚洲精品有码在线观看 I 国产在线亚州精品内射 I 亚洲综合欧美制服丝袜 I 日本大黄色片 I 成人射区 I 九九精品免费 I 秋霞国产午夜伦午夜福利片 I 亚洲精品天堂网 I 日韩在线播放av I 貂蝉艳史在线观看 I 亚洲日本韩国精品 I 午夜福利影院私人爽爽 I 国产免费这里只有精品 I 国产亚洲精品久久久久久动漫 I 欧美理论视频 I 天天干天天干 I 国产毛片久久久 I 一区二区三区在线播放 I 亚洲色一色噜一噜噜噜 I 亚洲黄色免费在线看 I 日韩精品一卡2卡三卡4卡 I 91.com在线

●Dr. Bertolino has over 30 years of domestic and global drug development and management experience.

●Dr. Bertolino held several key positions at Novartis Institutes for Biomedical Research (“NIBR”), including Vice President of Dermatology and Vice President & Global Head of Translational Medicine for Dermatology.

●Dr. Bertolino held positions as Senior Medical Director and Senior Director of Dermatology at Pfizer. Dr. Bertolino led FDA clinical interactions at entitlement meetings for Pfizer’s dermatology products and served as Pfizer’s dermatology spokesperson.

●Dr. Bertolino served as Chief Medical Officer and Vice President of Medical Affairs at Peplin, Inc., where he led Phase 2 programs and designed and drove initial Phase 3 programs that contributed to FDA approval of Picato? (ingenol mebutate).